-
IntroducedMar 01, 2024
-
Passed House
-
Passed Senate
-
Signed into Law
AN ACT RELATING TO INSURANCE -- BENEFIT DETERMINATION AND UTILIZATION REVIEW ACT (Limits the use by insurers of step therapy, a protocol that establishes a specific sequence in which prescription drugs for a specified medical condition are covered by an insurer, by allowing medical providers to request step therapy exceptions.)
Last Action See all actions
House • Mar 19, 2024: 03/19/2024 Committee recommended measure be held for further study
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 7822
Tweets
Whip Lists
Sponsors
Votes
Actions
- Mar 19, 2024 | House
- 03/19/2024 Committee recommended measure be held for further study
- Mar 15, 2024 | House
- 03/15/2024 Scheduled for hearing and/or consideration (03/19/2024)
- Mar 01, 2024 | House
- 03/01/2024 Introduced, referred to House Health & Human Services
Bill Texts
Documents
- 03/15/2024 Scheduled for hearing and/or consideration (03/19/2024)
- House Health and Human Services: 03-19-2024--H7822--ACS CAN-Ryan StrikPDF
- House Health and Human Services: 03-19-2024--H7822--ALS Association-Danielle AdamsPDF
- House Health and Human Services: 03-19-2024--H7822--Chronic Disease Coalition-Nathaniel BrownPDF
- House Health and Human Services: 03-19-2024--H7822--Newport Mental Health-Jamie LehanePDF
- House Health and Human Services: 03-19-2024--H7822--NORD-Carolyn SheridanPDF
- House Health and Human Services: 03-19-2024--H7822--PCMA-Sam HallemeierPDF
- House Health and Human Services: 03-19-2024--H7822--Prime Therapeutics-Michelle CrumminsPDF
- House Health and Human Services: 03-19-2024--H7822--RI Medical Society-Heather SmithPDF
- House Health and Human Services: 03-12-2024--H7822--Elizabeth Burke BryantPDF